 |
| Robert Califf photo credit: Christopher Michel / Flickr |
Califf previously held this position during 2016 under the Obama administration. During this time, the FDA extended the approved use of the abortion pill to the tenth week of gestation. Before then, the use of the abortion pill was limited to the first seven weeks of pregnancy.
Under Califf's direction, the FDA also modified regulations so that abortion businesses could give women abortion pills to take without medical supervision. The second part of the abortion pill regimen causes a woman to go into labor and "miscarry," her aborted child. Without supervision, this process could pose significant risks to the mother's health.
The FDA also decided in 2016 to alter regulations so that the abortion pill's manufacturer, Danco Laboratories, would no longer be required to report adverse events (other than death) linked to abortion pills. After this change, it has been impossible to know for sure just how many women have suffered complications after taking abortion pills.
Califf's past actions demonstrate that he is willing to sacrifice the safety of women to empower the abortion industry.